Community Health Systems, Inc. (NYSE:CYH) Q4 2021 Results Earnings Conference Call February 17, 2022 11:00 AM ET Company Participants Ross Comeaux - VP, IR Tim Hingtgen - CEO Kevin Hammons - President & CFO Lynn Simon - President of Clinical Operations & Chief Medical Officer Conference Call Participants Brian Tanquilut - Jefferies Josh Raskin - Nephron Research Kevin Fischbeck - Bank of America Ben Hendrix - RBC Capital Markets Jason Cassorla - Citi Andrew Mok - UBS Operator Good day. And thank you for sta ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 13-3893191 (State or other juris ...

Financial Data and Key Metrics Changes - In Q3 2021, consolidated net operating revenues reached $3.115 billion, with same-store net revenue increasing by 7.1% year-over-year [17] - Adjusted EBITDA was $482 million, up 7% year-over-year, with an adjusted EBITDA margin of 14.8% [10][18] - Excluding pandemic relief funds, adjusted EBITDA was $463 million, reflecting a 19% increase compared to Q3 2019 [10][18] Business Line Data and Key Metrics Changes - Same-store admissions increased by 2.8%, adjusted admissions rose by 4.7%, and surgeries grew by 1.5% [8] - Emergency room visits surged by 24.2%, indicating a strong recovery in non-COVID healthcare demand [8] - Compared to pre-pandemic Q3 2019, same-store admissions decreased by 3%, while surgeries declined by 4% [8] Market Data and Key Metrics Changes - The company provided care for approximately 15,000 inpatient COVID admissions, representing 13% of total admissions, marking the highest quarterly case count to date [6] - Non-COVID healthcare demand was higher in Q3 2021 than in previous quarters with elevated COVID-19 cases [9] Company Strategy and Development Direction - The company is focused on growth strategies, including investments in bed capacity, outpatient access points, and physician recruitment [12] - Recent investments include new joint ventures in rehab, long-term acute care, and behavioral health, as well as expansions in existing facilities [13][14] - The company is optimistic about its portfolio and market opportunities, raising adjusted EBITDA guidance for the full year [15][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in managing costs despite increased staffing and supply expenses due to COVID-19 [11][29] - The company anticipates a return of deferred healthcare demand over the next several quarters [9] - Management highlighted the importance of their strategic margin improvement program, which is expected to drive efficiency and cost savings [19] Other Important Information - Cash flows from operations for the first nine months of 2021 were $400 million, compared to $2.1 billion in the same period of 2020 [20] - The company had $1.3 billion in cash on the balance sheet as of September 30, 2021, with no outstanding borrowings [22] Q&A Session Summary Question: Concerns about cost management and revenue initiatives - Management discussed their margin improvement program and initiatives in supply chain management to reduce costs while managing increased labor expenses due to COVID-19 [28][29] Question: Breakdown of contract labor usage and non-COVID volumes - Management noted that contract labor costs increased significantly but were offset by savings in other areas, and non-COVID volumes showed strong performance despite some deferrals [36][38] Question: Demographic shifts and market share changes - Management acknowledged anecdotal evidence of urban flight to suburban markets, positioning the company well for growth in those areas [41][42] Question: Volume trends into October and non-COVID utilization rebound - Management indicated that while COVID admissions peaked in late August, non-COVID care is expected to rebound as deferred cases are addressed [44][46] Question: Core margin discussion and normalization - Management believes current margins are a good indicator of operational performance and expects continued progress towards their medium-term margin targets [50]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ________ Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. | --- | --- | |--------------------------------------------------- ...

Community Health Systems Inc. (NYSE:CYH) Q2 2021 Earnings Conference Call July 29, 2021 11:00 AM ET Company Participants Ross Comeaux - Vice President of Investor Relations Tim Hingtgen - CEO & Director Kevin Hammons - President & CFO Lynn Simon - President of Clinical Operations & Chief Medical Officer Conference Call Participants Brian Tanquilut - Jefferies Frank Morgan - RBC Capital Markets Josh Raskin - Nephron Research A.J. Rice - Crédit Suisse Ralph Giacobbe - Citi Steven Valiquette - Barclays Kevin F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ________ Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 13-3893 ...

Earnings Presentation — 1গ্ Quarter, 2021 Community alth Systems Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. All statements in this presentation other than statements of historical fact, including statements regarding projections, expected operat ...

Community Health Systems, Inc. (NYSE:CYH) Q1 2021 Earnings Conference Call April 29, 2021 11:00 AM ET Company Participants Ross Comeaux - Vice President and Investor Relations Tim Hingtgen - Chief Executive Officer Lynn Simon - President, Clinical Operations and Chief Medical Officer Kevin Hammons - President and Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Frank Morgan - RBC Capital Markets Jack Slevin - Jefferies Ralph Giacobbe - Citi Kevin Fischbeck - Bank of Americ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ________ Commission file number 001-15925 COMMUNITY HEALTH SYSTEMS, INC. | --- | --- | --- | |------------------------------------------------- ...

J.P. Morgan Global High Yield & Leveraged Finance Conference March 2, 2021 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. All statements in this presentation other than statements of historical fact, including statements regarding projections, exp ...